Advanced search
Publication Cover
Current Medical Research and Opinion Volume 30, 2014 - Issue 2
Submit an article Journal homepage
387
Views
14
CrossRef citations to date
0
Altmetric
Psychiatry: Original article

Early and sustained improvement with vilazodone in adult patients with major depressive disorder: post hoc analyses of two phase III trials

Rakesh JainAssociate Clinical Professor, Department of Psychiatry & Behavioral Sciences, University of Texas Medical School Houston, TXUSACorrespondence[email protected]
,
Dalei ChenForest Research Institute Jersey City, NJUSA
,
John EdwardsForest Research Institute Jersey City, NJUSA
&
Maju MathewsForest Research Institute Jersey City, NJUSA
Pages 263-270 | Accepted 10 Oct 2013, Published online: 31 Oct 2013

Citations (14)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Xiao-Fei Zhang, Lei Wu, Dong-Jun Wan, Ruo-Zhuo Liu, Zhao Dong, Min Chen & Sheng-Yuan Yu. (2015) Evaluation of the efficacy and safety of vilazodone for treating major depressive disorder. Neuropsychiatric Disease and Treatment 11, pages 1957-1965.
Read now
Zheng-Yi Zhou, Shawn Sun, Pooja Chopra, Yichen Zhong, Todor Totev & James Signorovitch. (2015) Health resource use and costs of vilazodone and other selective serotonin re-uptake inhibitors in treating major depressive disorder. Journal of Medical Economics 18:11, pages 919-929.
Read now
William James Deardorff & George T Grossberg. (2014) A review of the clinical efficacy, safety and tolerability of the antidepressants vilazodone, levomilnacipran and vortioxetine. Expert Opinion on Pharmacotherapy 15:17, pages 2525-2542.
Read now

Articles from other publishers (11)

Mujeeb U. Shad. (2023) Recent Developments in Pharmacotherapy of Depression: Bench to Bedside. Journal of Personalized Medicine 13:5, pages 773.
Crossref
Frank Faltraco & Johannes Thome. 2020. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy 1 7 .
Frank Faltraco & Johannes Thome. 2022. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy 1311 1317 .
Le Wang, Yanming Zhang, Xia Du, Teng Ding, Weiling Gong & Feng Liu. (2019) Review of antidepressants in clinic and active ingredients of traditional Chinese medicine targeting 5-HT1A receptors. Biomedicine & Pharmacotherapy 120, pages 109408.
Crossref
Tina H. Byun, Swarna S. Chaliki & Kenneth G. PooleJrJr. (2019) New Treatment Options for Depression: A Primer for Internists. The American Journal of Medicine 132:6, pages 678-684.
Crossref
Alan F. Schatzberg & Charles DeBattista. 2019. Schatzberg’s Manual of Psychopharmacology. Schatzberg’s Manual of Psychopharmacology.
Przemysław Paweł Taciak, Natalia Lysenko & Aleksander Paweł Mazurek. (2018) Drugs which influence serotonin transporter and serotonergic receptors: Pharmacological and clinical properties in the treatment of depression. Pharmacological Reports 70:1, pages 37-46.
Crossref
Stephan Hjorth. (2016) Looking back (and in)to the future: A personal reflection on ‘Serotonin autoreceptor function and antidepressant drug action’ (Hjorth et al., 2000). Journal of Psychopharmacology 30:11, pages 1129-1136.
Crossref
Sheng-Min WangChangsu HanSoo-Jung LeeAshwin A. PatkarPrakash S MasandChi-Un Pae. (2016) Vilazodone for the Treatment of Depression: An Update. Chonnam Medical Journal 52:2, pages 91.
Crossref
James McKean, Hannah Watts & Robert Mokszycki. (2015) Breakthrough Seizures after Starting Vilazodone for Depression. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 35:3, pages e6-e8.
Crossref
Sheng-Min WangChangsu HanSoo-Jung LeeAshwin A PatkarPrakash S MasandChi-Un Pae. (2015) Vilazodone for the Treatment of Major Depressive Disorder: Focusing on Its Clinical Studies and Mechanism of Action. Psychiatry Investigation 12:2, pages 155.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.